Skip to main content
OpenTrials
Completed

NCT Number: NCT01860274

Meshed Vein Graft Patency Trial - VEST

The study hypothesis is that a meshed conduit made of safen vein allows a better patency at mid-long term than a safen vein alone.

To test this hypothesis the investigators plan a prospective, randomized study, comparing grafts to the diagonal, in cases of vessel diameter under 1.5mm. A control angiography will be performed one year after the operation.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

European Hospital, Rome, Italy

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical Indication for elective Coronary Artery Bypass Grafting with at least one vein graft
  • Coronary artery with critical stenosis (over 70%)

Exclusion criteria

-

Treatment and study plan

External Mesh for vein grafts

Device

Primary outcomes

  1. Patency

    Time frame: 6 to 12 months

    Patency of graft at CT Scan

Secondary outcomes

  1. Major Adverse Cardiac and Cerebrovascular Events (MACCE)

    Time frame: 60 months

  2. Vein graft lumen uniformity

    Time frame: 6 to 12 months

Sponsors and collaborators

Lead sponsor

Cardiochirurgia E.H.

Other

Registry information

Official study title

External Mesh of Vein Grafts In Coronary Artery Bypass Grating: Early Patency and Clinical Outcome

Important dates

Study start
2015
Primary completion
2019
Study completion
2020
First posted
May 22, 2013
Registry last updated
Mar 12, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.